Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Condition:   Head and Neck Cancer
Interventions:   Drug: Pembrolizumab;   Drug: Clopidogrel;   Drug: acetylsalicylic acid
Sponsor:   Medical University of South Carolina
Not yet recruiting - verified July 2017

http://ift.tt/2wLnVrR